RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

It's kind of amusing reading this. Let's see--what do we know? We know that the last PR stated that the RD trials were starting, without any caveats. We should be pretty certain that on May 14, we'll know how they went, because by then Cortex management will know whether subjects were indeed prevented from going into RD by CX717--and their mood will tell all, regardless of whether formal announcements are held until the data is unblinded. We know that Org26576 has been put into Phase II trials for ADHD and depression by Schering-Plough, which speaks to the 'other irons in the fire' issue. And we know that for the first time ever, Cortex has a high-impact Ampakine (CX-1837)in late preclinical preparation for clinical trials (another 'iron'.)

Now for my opinion--there is absolutely nothing pathological in the recent trading, the price has stayed in a very narrow range on low volume. If this is predictive of a "huge sell-off", kindly present your data--I doubt that there is any.

I have two questions for you, Iggs:
1) Could you try to be a little less obvious?
2) Are you by any chance pinned down by sniper fire at an airport?

NeuroInvestment